D. Stetsko

发表

IL-12 and IL-23 in health and disease

D. Sauder, D. Stetsko, 2008, Expert review of clinical immunology.

Biology and Molecular Biology of Epidermal Cell‐Derived Thymocyte Activating Factor a

C. Harley, D. Sauder, R. Mckenzie, 1988, Annals of the New York Academy of Sciences.

B cells from African American lupus patients exhibit an activated phenotype.

P. M. Davis, Clarence K. Zhang, S. Nadler, 2016, JCI insight.

Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity

K. McIntyre, Wen-pin Yang, S. Ruepp, 2017, The Journal of Immunology.

This information is current as Demonstrates Steroid Sparing Activity Disease in Murine Lupus Models and Selective IRAK 4 Inhibition Attenuates

K. McIntyre, Wen-pin Yang, S. Ruepp, 2016 .

A Monovalent Anti-Human CD28 Domain Antibody Antagonist: Preclinical Efficacy and Safety

P. M. Davis, S. Grant, J. Bryson, 2013, The Journal of Immunology.

Expression of mRNA homologous to interleukin 1 in human epidermal cells.

C. Harley, D. Sauder, T. Bell, 1987, The Journal of investigative dermatology.

Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis)

Radhey S. Gupta, A. Chopra, D. Stetsko, 1986, Journal of cellular physiology.

Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO induction.

P. M. Davis, S. Nadler, S. Suchard, 2008, Clinical immunology.

Design of LFA-1 antagonists based on a 2,3-dihydro-1H-pyrrolizin-5(7aH)-one scaffold.

J. Barrish, S. Sheriff, M. Poss, 2007, Bioorganic & medicinal chemistry letters.

An LFA-1 (αLβ2) Small-Molecule Antagonist Reduces Inflammation and Joint Destruction in Murine Models of Arthritis

P. M. Davis, K. McIntyre, D. Shuster, 2010, The Journal of Immunology.

Small molecule antagonist of leukocyte function associated antigen-1 (LFA-1): structure-activity relationships leading to the identification of 6-((5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic acid (BMS-688521).

P. M. Davis, K. McIntyre, J. Barrish, 2010, Journal of medicinal chemistry.

Discovery and development of 5-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl-methyl]-3-thiophenecarboxylic acid (BMS-587101)--a small molecule antagonist of leukocyte function associated antigen-1.

P. M. Davis, V. Goldfarb, D. Cheney, 2006, Journal of medicinal chemistry.

Human interleukin-1α is chemotactic for normal human keratinocytes

F. Orr, R. Chizzonite, P. Kilian, 1989 .

2B4 (CD244) induced by selective CD28 blockade functionally regulates allograft-specific CD8+ T cell responses

S. Nadler, M. Ford, S. Krummey, 2014, The Journal of experimental medicine.